Please enable JavaScript to continue using this application.

Compare $HRTX vs $SERA | Chartloom

Compare

$HRTX vs $SERA

Heron Therapeutics Inc · Sera Prognostics Inc

HRTX

Heron Therapeutics Inc

SERA

Sera Prognostics Inc

Compare $HRTX vs $SERA

Comparing Heron Therapeutics Inc and Sera Prognostics Inc

HRTXHeron Therapeutics Inc

SERASera Prognostics Inc

HRTXHeron Therapeutics Inc

Market cap

$77M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

1.0%

YTD performance

-67.8%

52W performance

-69.9%

FCF yield

-15.8%

SERASera Prognostics Inc

Market cap

$80M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

89.94x

Rev growth (TTM)

-35.2%

YTD performance

-32.0%

52W performance

-35.2%

FCF yield

-35.3%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

HRTX

SERA

Detailed metrics comparison

HRTX

Heron Therapeutics Inc

SERA

Sera Prognostics Inc

Market Cap

HRTX$77M

SERA$80M

Enterprise Value

HRTX$199M

SERA$75M

Price

HRTX$0.41

SERA$2.04

P/E Ratio

HRTXN/A

SERAN/A

P/S Ratio

HRTX0.51x

SERA1,141.23x

EV/Sales

HRTX1.31x

SERA1,078.41x

EV/EBITDA

HRTX79.76x

SERA0.00x

P/B Ratio

HRTX9.55x

SERA1.39x

P/FCF Ratio

HRTXN/A

SERAN/A

EV/FCF

HRTX-16.38x

SERA-2.68x

PEG Ratio

HRTXN/A

SERAN/A

Forward P/E (NTM)

HRTXN/A

SERAN/A

Forward P/S (NTM)

HRTXN/A

SERA89.94x

Revenue (TTM)

HRTX$151M

SERA$70K

Revenue Growth (YoY)

HRTX1.0%

SERA-35.2%

Forward Rev Growth

HRTX-1.6%

SERA791.9%

Gross Margin (TTM)

HRTX70.1%

SERA-150.0%

Operating Margin (TTM)

HRTX0.0%

SERA0.0%

EBITDA Margin (TTM)

HRTX-5.8%

SERA-50200.0%

Net Margin (TTM)

HRTX-22.5%

SERA-47475.7%

FCF Margin (TTM)

HRTX-8.0%

SERA-40262.9%

Net Income (TTM)

HRTX$-34M

SERA$-33M

FCF (TTM)

HRTX$-12M

SERA$-28M

EPS (TTM)

HRTX-$0.18

SERA-$0.66

ROE (TTM)

HRTX-30090.0%

SERA-4671.0%

ROA (TTM)

HRTX-1357.0%

SERA-3406.0%

ROIC (TTM)

HRTX-2233.0%

SERA-4671.0%

Cash

HRTX$21M

SERA$4M

Debt

HRTX$143M

SERA$0

Net Cash/Debt

HRTX$-122M

SERA$4M

Current Ratio (TTM)

HRTX2.49x

SERA1.98x

Quick Ratio (TTM)

HRTX1.44x

SERA1.91x

Debt/Equity (TTM)

HRTX20.65x

SERA0.00x

Debt/Assets (TTM)

HRTX0.0%

SERA0.0%

Interest Coverage (TTM)

HRTXN/A

SERAN/A

Net Debt/EBITDA (TTM)

HRTX0.00x

SERA0.00x

Beta

HRTX1.65

SERA1.09

52W Performance

HRTX-69.9%

SERA-35.2%

YTD Performance

HRTX-67.8%

SERA-32.0%

% from 52W High

HRTX-74.3%

SERA-48.4%

% from 52W Low

HRTX55.6%

SERA30.8%

Asset Turnover (TTM)

HRTX0.60x

SERA0.00x

FCF Yield (TTM)

HRTX-15.8%

SERA-35.3%

Earnings Yield (TTM)

HRTX-44.3%

SERA-41.6%

Dividend Yield (TTM)

HRTXN/A

SERAN/A

Rule of 40

HRTX-7.0

SERA-40,298.0

EV/GP/RG

HRTXN/A

SERAN/A

Ticker research

View HRTX research View SERA research

Metric	HRTX Heron Therapeutics Inc	SERA Sera Prognostics Inc
Market & Valuation
Market Cap	$77M	$80M
Enterprise Value	$199M	$75M
Price	$0.41	$2.04
P/E Ratio	N/A	N/A
P/S Ratio	0.51x	1,141.23x
EV/Sales	1.31x	1,078.41x
EV/EBITDA	79.76x	0.00x
P/B Ratio	9.55x	1.39x
P/FCF Ratio	N/A	N/A
EV/FCF	-16.38x	-2.68x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	89.94x
Revenue & Growth
Revenue (TTM)	$151M	$70K
Revenue Growth (YoY)	1.0%	-35.2%
Forward Rev Growth	-1.6%	791.9%
Profitability
Gross Margin (TTM)	70.1%	-150.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-5.8%	-50200.0%
Net Margin (TTM)	-22.5%	-47475.7%
FCF Margin (TTM)	-8.0%	-40262.9%
Net Income (TTM)	$-34M	$-33M
FCF (TTM)	$-12M	$-28M
EPS (TTM)	-$0.18	-$0.66
ROE (TTM)	-30090.0%	-4671.0%
ROA (TTM)	-1357.0%	-3406.0%
ROIC (TTM)	-2233.0%	-4671.0%
Financial Health
Cash	$21M	$4M
Debt	$143M	$0
Net Cash/Debt	$-122M	$4M
Current Ratio (TTM)	2.49x	1.98x
Quick Ratio (TTM)	1.44x	1.91x
Debt/Equity (TTM)	20.65x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.65	1.09
52W Performance	-69.9%	-35.2%
YTD Performance	-67.8%	-32.0%
% from 52W High	-74.3%	-48.4%
% from 52W Low	55.6%	30.8%
Efficiency & Yields
Asset Turnover (TTM)	0.60x	0.00x
FCF Yield (TTM)	-15.8%	-35.3%
Earnings Yield (TTM)	-44.3%	-41.6%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-7.0	-40,298.0
EV/GP/RG	N/A	N/A
Ticker research	View HRTX research	View SERA research

Valuation

P/S Ratio

HRTX

0.51x

SERA

1,141.23x

EV/FCF

HRTX

-16.38x

SERA

-2.68x

Growth & revenue

Revenue Growth TTM

HRTX

1.0%

SERA

-35.2%

Forward Revenue Growth

SERA

791.9%

HRTX

-1.6%

Profitability & performance

Gross Margin

HRTX

70.1%

SERA

-150.0%

ROE

SERA

-4671.0%

HRTX

-30090.0%

FCF Yield %

HRTX

-15.8%

SERA

-35.3%

52-Week Performance

SERA

-35.2%

HRTX

-69.9%

Detailed metrics comparison

HRTX

Heron Therapeutics Inc

SERA

Sera Prognostics Inc

Market Cap

HRTX$77M

SERA$80M

Enterprise Value

HRTX$199M

SERA$75M

Price

HRTX$0.41

SERA$2.04

P/E Ratio

HRTXN/A

SERAN/A

P/S Ratio

HRTX0.51x

SERA1,141.23x

EV/Sales

HRTX1.31x

SERA1,078.41x

EV/EBITDA

HRTX79.76x

SERA0.00x

P/B Ratio

HRTX9.55x

SERA1.39x

P/FCF Ratio

HRTXN/A

SERAN/A

EV/FCF

HRTX-16.38x

SERA-2.68x

PEG Ratio

HRTXN/A

SERAN/A

Forward P/E (NTM)

HRTXN/A

SERAN/A

Forward P/S (NTM)

HRTXN/A

SERA89.94x

Revenue (TTM)

HRTX$151M

SERA$70K

Revenue Growth (YoY)

HRTX1.0%

SERA-35.2%

Forward Rev Growth

HRTX-1.6%

SERA791.9%

Gross Margin (TTM)

HRTX70.1%

SERA-150.0%

Operating Margin (TTM)

HRTX0.0%

SERA0.0%

EBITDA Margin (TTM)

HRTX-5.8%

SERA-50200.0%

Net Margin (TTM)

HRTX-22.5%

SERA-47475.7%

FCF Margin (TTM)

HRTX-8.0%

SERA-40262.9%

Net Income (TTM)

HRTX$-34M

SERA$-33M

FCF (TTM)

HRTX$-12M

SERA$-28M

EPS (TTM)

HRTX-$0.18

SERA-$0.66

ROE (TTM)

HRTX-30090.0%

SERA-4671.0%

ROA (TTM)

HRTX-1357.0%

SERA-3406.0%

ROIC (TTM)

HRTX-2233.0%

SERA-4671.0%

Cash

HRTX$21M

SERA$4M

Debt

HRTX$143M

SERA$0

Net Cash/Debt

HRTX$-122M

SERA$4M

Current Ratio (TTM)

HRTX2.49x

SERA1.98x

Quick Ratio (TTM)

HRTX1.44x

SERA1.91x

Debt/Equity (TTM)

HRTX20.65x

SERA0.00x

Debt/Assets (TTM)

HRTX0.0%

SERA0.0%

Interest Coverage (TTM)

HRTXN/A

SERAN/A

Net Debt/EBITDA (TTM)

HRTX0.00x

SERA0.00x

Beta

HRTX1.65

SERA1.09

52W Performance

HRTX-69.9%

SERA-35.2%

YTD Performance

HRTX-67.8%

SERA-32.0%

% from 52W High

HRTX-74.3%

SERA-48.4%

% from 52W Low

HRTX55.6%

SERA30.8%

Asset Turnover (TTM)

HRTX0.60x

SERA0.00x

FCF Yield (TTM)

HRTX-15.8%

SERA-35.3%

Earnings Yield (TTM)

HRTX-44.3%

SERA-41.6%

Dividend Yield (TTM)

HRTXN/A

SERAN/A

Rule of 40

HRTX-7.0

SERA-40,298.0

EV/GP/RG

HRTXN/A

SERAN/A

Ticker research

View HRTX research View SERA research

Metric	HRTX Heron Therapeutics Inc	SERA Sera Prognostics Inc
Market & Valuation
Market Cap	$77M	$80M
Enterprise Value	$199M	$75M
Price	$0.41	$2.04
P/E Ratio	N/A	N/A
P/S Ratio	0.51x	1,141.23x
EV/Sales	1.31x	1,078.41x
EV/EBITDA	79.76x	0.00x
P/B Ratio	9.55x	1.39x
P/FCF Ratio	N/A	N/A
EV/FCF	-16.38x	-2.68x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	89.94x
Revenue & Growth
Revenue (TTM)	$151M	$70K
Revenue Growth (YoY)	1.0%	-35.2%
Forward Rev Growth	-1.6%	791.9%
Profitability
Gross Margin (TTM)	70.1%	-150.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-5.8%	-50200.0%
Net Margin (TTM)	-22.5%	-47475.7%
FCF Margin (TTM)	-8.0%	-40262.9%
Net Income (TTM)	$-34M	$-33M
FCF (TTM)	$-12M	$-28M
EPS (TTM)	-$0.18	-$0.66
ROE (TTM)	-30090.0%	-4671.0%
ROA (TTM)	-1357.0%	-3406.0%
ROIC (TTM)	-2233.0%	-4671.0%
Financial Health
Cash	$21M	$4M
Debt	$143M	$0
Net Cash/Debt	$-122M	$4M
Current Ratio (TTM)	2.49x	1.98x
Quick Ratio (TTM)	1.44x	1.91x
Debt/Equity (TTM)	20.65x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.65	1.09
52W Performance	-69.9%	-35.2%
YTD Performance	-67.8%	-32.0%
% from 52W High	-74.3%	-48.4%
% from 52W Low	55.6%	30.8%
Efficiency & Yields
Asset Turnover (TTM)	0.60x	0.00x
FCF Yield (TTM)	-15.8%	-35.3%
Earnings Yield (TTM)	-44.3%	-41.6%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-7.0	-40,298.0
EV/GP/RG	N/A	N/A
Ticker research	View HRTX research	View SERA research